IP Library Granted Patent US 9,598,480
Granted Patent B2
US 9,598,480 · App. 13/769,222 · Granted Mar 21, 2017

Recombinant NEL-like (NELL) protein production

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,598,480
App. No.
13/769,222
Granted
Mar 21, 2017
Kind
B2
Abstract

The present invention provides a method and system for producing a NELL protein. The method and system comprise a CELL encoding a NELL protein or peptide and a non-insect secretory signal peptide.

Claims (27)

1. A method of expressing a peptide in a mammalian cell comprising:

providing a nucleic acid construct including at least a nucleic acid encoding at least a NEL-like protein (NELL) peptide in frame with a nucleic acid encoding a heterologous, non-insect secretory signal peptide;

transfecting a mammalian cell with the nucleic acid construct;

culturing the mammalian cell under conditions that permit expression of the NELL peptide;

collecting NELL peptide secreted from the cell; and

substantially purifying the NELL peptide using a chromatography process that uses membrane chromatography or affinity chromatography;

wherein the nucleic acid encodes NELL1 or NELL2, wherein NELL1 is selected from the group consisting of: SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, and SEQ ID NO:6,

wherein NELL2 is selected from the group consisting of: SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, and SEQ ID NO:14.

2. The method of claim 1 , wherein the mammalian cell is a Chinese hamster ovary (CHO) cell.

3. The method of claim 1 , wherein substantially purifying comprises membrane chromatography.

4. The method of claim 3 , further comprising

testing the activity of the NELL peptide to induce bone formation.

5. The method of claim 1 , further comprising

testing the activity of the NELL peptide to induce bone formation.

6. The method of claim 1 , wherein substantially purifying comprises affinity chromatography.

7. The method of claim 1 , wherein the non-insect secretory signal peptide is a plant secretory signal peptide or an animal secretory signal peptide, wherein the animal secretory signal peptide is a mammalian secretory signal peptide.

8. A nucleic acid construct for expressing a NEL-like protein (NELL peptide) in a mammalian cell, the nucleic acid construct comprising at least a nucleic acid encoding at least a NELL peptide in frame with a nucleic acid encoding a heterologous non-insect signal peptide that is a non-insect secretory signal peptide;

wherein the nucleic acid encodes NELL1 or NELL2, wherein the NELL1 is selected from the group consisting of: SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, and SEQ ID NO:6; and

wherein NELL2 is selected from the group consisting of: SEQ ID NO:7, SEQ ID NO: 8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, and SEQ ID NO:14.

9. The nucleic acid construct of claim 8 , wherein the mammalian cell is a CHO cell.

10. The nucleic acid construct of claim 8 , wherein the non-insect secretory signal peptide is a plant secretory signal peptide or an animal secretory signal peptide, wherein the animal secretory signal peptide is a mammalian secretory signal peptide.

11. A mammalian cell line for expressing a NEL-like protein (NELL) peptide, the cell line including a nucleic acid construct comprising at least a nucleic acid encoding at least a NELL peptide in frame with a nucleic acid encoding a heterologous non-insect signal peptide that is a non-insect secretory signal peptide;

wherein the nucleic acid encodes NELL or NELL2 peptide, wherein NELL1 is selected from the group consisting of: SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, or SEQ ID NO:6; and

wherein NELL2 is selected from the group consisting of: SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, and SEQ ID NO:14.

12. The cell of claim 11 , wherein the mammalian cell line comprises a CHO cell.

13. The cell of claim 12 , wherein the CHO cell secretes NELL1 or NELL2 peptide.

14. The cell line of claim 11 , wherein the non-insect secretory signal peptide is a plant secretory signal peptide or an animal secretory signal peptide, and wherein the animal secretory signal peptide is a mammalian secretory signal peptide.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME TO: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA PREVIOUSLY RECORDED ON REEL 030749 FRAME 0238. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 23, 2013
From: TING, KANG; SOO, B. CHIA
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 030889/0194 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2013
From: TING, KANG; SOO, B. CHIA
To: THE REGENTS OF THE UNVERSITY OF CALIFORNIA
Reel/Frame 030749/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2013
From: TING, KANG; SOO, B. CHIA
To: THE REGENTS OF THE UNVERSITY OF CALIFORNIA
Reel/Frame 030711/0136 →
CONFIRMATORY LICENSE Recorded Jun 7, 2013
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030574/0771 →
CONFIRMATORY LICENSE Recorded Mar 27, 2013
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030102/0163 →